Metaphase and interphase cytogenetics in fibroadenomas of the breast

In Vivo

Volumn 18, Issue 6, 2004, Pages 703-712

  Rizou, Helen ^a   Bardi, Georgia ^a   Arnaourti, Maria ^a   Apostolikas, Nikiforos ^a   Sfikas, Kostas ^b   Charlaftis, Antonios ^c   Polichronis, Athanassios ^c   Agnantis, Niki J ^d   Pandis, Nikos ^a  

^a SAINT SAVVAS HOSPITAL   (Greece)

^b HELENA VENIZELOU HOSPITAL   (Greece)

^c Breast Unit   (Greece)

^d UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Breast lesions; c MYC; CCND1; Cytogenetic aberration; Fibroadenoma; FISH; Gene amplification; HER 2 neu

Indexed keywords

CYSTEINE RICH PROTEIN 61; EPIDERMAL GROWTH FACTOR RECEPTOR 2; MYC PROTEIN;

ARTICLE; BREAST CANCER; BREAST CARCINOMA; BREAST FIBROADENOMA; CANCER CELL CULTURE; CANCER RISK; CHROMOSOME ANALYSIS; CONTROLLED STUDY; DIPLOIDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE LOCUS; GENE MUTATION; GENE REARRANGEMENT; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERPHASE; KARYOTYPE; METAPHASE; TUMOR GROWTH;

EID: 11844293468     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Pandis N, Idvall I and Bardi G: Correlation between karyotypic pattern and clinicopathologic features in 125 breast cancer cases. Int J Cancer 66: 191-196, 1996.
2. Slamon DJ, Godolpin W and Jones IA: Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244(4905): 707-712, 1989.
3. Fantl V, Smith R, Brookes S, Dickson C and Peters G: Chromosome 11q13 abnormalities in human breast cancer. Cancer Surv 18 77-94, 1993.
4. Escot C, Theillet C, Lidereau R, Spyratos F, Champeme MH, Gest J and Callahan R: Genetic alteration of the c-myc protooncogene (MYC) in human primary breast carcinomas. Proc Natl Acad Sci USA 83: 4834-4838, 1986.
5. Lundin CP, Mertens F, Rizou H, Idvall I, Georgiou G, Ingvar C and Pandis N: Cytogenetic changes in benign proliferative and nonproliferative lesions of the breast. Cancer Genet Cytogenet 107: 118-120, 1998.
6. Page DL and Anderson T: Diagnostic Histopathology of the Breast. Churchill Livingstone (eds), New York, 1987.
7. Houlihan MJ: Fibroadenoma and hamartoma. In: Diseases of the Breast. Harris JR, Morrow M, Lippman S, Hellman M(eds), Philadelphia, pp45-48, 1996.
8. Lundin C and Mertens F: Cytogenetics of benign breast lesions. Breast Cancer Res Treat 51: 1-15, 1998.
9. Pauletti G, Godolphin W, Press MF and Slamon DJ: Detection and quantitation of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization. Oncogene 13: 6302, 1996.
10. Heim S: Is cancer cytogenetics reducible to the molecular genetics of cancer cells? Genes Chromosomes Cancer 5: 188-196, 1992.
11. Pandis N, Heim S, Bardi G, Limon J, Mandahl N and Mitelman F: Improved technique for short-term culture and cytogenetic analysis of human breast cancer. Genes Chromosomes Cancer 5: 14-20, 1992.
12. Dietrich CU, Pandis N, Andersen JA and Heim S: Chromosome abnormalities in adenolipomas of the breast: Karyotypic evidence that the mesenchymal component constitutes the neoplastic parenchyma. Cancer Genet Cytogenet 72: 146-150, 1994.
13. ISCN: An International System for Human Cytogenetic Nomenclature. Mitelman F (eds). Karger, Basel, 1995.
14. Mitelman Data Base of Chromosome Aberrations. Mitelman F, Johansson B, Mertens F (eds) http://cgap.nci.gov/Chromosomes/Mitelman, 2000.
15. Ojopi EPB, Rogatto SR, Caldeira JR, Barbieri-Neto J and Squire JA: Comparative genomic hybridization detects novel amplifications in fibroadenomas of the breast. Genes Chromosomes Cancer 30(1): 25-31, 2001.
16. Cavalli LR, Cornelio DA, Wuicik L, Bras AT, Ribeiro EM, Lima RS, Urban CA, Rogatto SR and Cavalli IJ: Clonal chromosome alterations in fibroadenomas of the breast. Cancer Genet Cytogenet 131: 120-124, 2001.
17. Teixeira MR, Pandis N and Heim S: Cytogenetic clues to breast carcinogenesis. Genes Chromosomes Cancer 33(1): 1-16, 2002.
18. Pandis N, Yin Y, Limon J, Bardi G, Idvall I, Mandahl N, Mitelman F and Heim S: Interstitial deletion of the short arm of chromosome 3 as a primary chromosome abnormality in carcinomas of the breast. Genes Chromosomes Cancer 6: 151-155, 1993.
19. Petersson C, Pandis N, Rizou H, Mertens F, Dietrich CU, Adeyinca A, Idvall I, Bondeson L, Georgiou G, Ingvar C, Heim S and Mitelman F: Karyotypic abnormalities in fibroadenomas of the breast. Int J Cancer 70: 282-286, 1997.
20. Staats B, Bonk U, Wanschura S, Hanisch P, Schoenmakers EF, Van den Ven WJ, Bartnitzke S and Bullerdiek J: A fibroadenoma with a t(4;12)(q27;q15) affecting the HMGI-C gene, a member of the high mobility group protein gene family. Breast Cancer Res Treat 38: 299-303, 1996.
21. Dietrich CU, Pandis N, Teixeira MR, Bardi G, Gerdes A-M, Andersen JA and Heim S: Chromosome abnormalities in benign hyperproliferative disorders of epithelial and stromal breast tissue. Int J Cancer 60: 49-53, 1995.
22. Radice P and Pierotti MA: Molecular genetics of breast cancer. Q J Nucl Med 41: 189-199, 1997.
23. Fletcher JA, Pinkus GS, Weidner N and Morton CC: Lineage-restricted clonality in biphasic solid tumors. Am J Pathol 138 1199-1207, 1991.
24. Dal Cin P, Pauwels P, Moerman P, Heng Q and Van den Berghe H: Hyperdiploidy in benign breast lesions. Cancer Genet Cytogenet 101: 162-163, 1998.
25. Adeyinca A, Mertens F, Idvall I, Bondeson L and Pandis N: Multiple polysomies in breast carcinomas: preferential gain of chromosomes 1,5,6,7,12,16,17,18 and 19. Cancer Genet Cytogenet 111: 144-148, 1999.
26. Pandis N, Jin Y, Gorunova L, Petersson C, Bardi G, Idvall I, Johansson B, Ingvar C, Mandahl N, Mitelman F and Heim S: Chromosome analysis of 97 primary breast carcinomas: identification of eight karyotypic subgroups. Genes Chromosomes Cancer 12: 173-185, 1995.
27. Bieche I and Lidereau R: Genetic alterations in breast cancer. Genes Chromosomes Cancer 14: 227-251, 1995.
28. Tsukamoto F, Miyoshi Y, Koyama H, Watatami M, Sasa M, Shiba E, Takami S, Inazawa J and Noguchi S: Detection of chromosomal aneusomy by fluorescence in situ hybridization in fine-needle aspirates from breast tumours: application to the preoperative diagnosis of breast carcinoma. Cancer 90(6): 373-378, 2000.
29. Amiel A, Kaufman Z, Goldstein E, Bruchim RB, Kidron D, Gaber E and Fejgin MD: Application of comparative genomic hybridization in search for genetic aberrations in fibroadenomas of the breast. Cancer Genet Cytogenet 142(2): 145-8, 2003.
30. Ried T, Just KE, Holtgreve-Grez H, du Manoir S, Speicher MR, Schrock E, Latham C, Blegen H, Zetterberg A, Cremer T and Auer G: Comparative genomic hybridization of formalin-fixed, paraffin-embedded breast tumors reveals different patterns of chromosomal gains and losses in fibroadenomas and aneuploid carcinomas. Cancer Res 55: 5415-5423, 1995.
31. Selim AG, El-Ayat G and Wells CA: c-erbB2 oncoprotein expression, gene amplification, and chromosome 17 aneusomy in apocrine adenosis of the breast. J Pathol 191(2): 138-142, 2000.
32. Moore JG, To V, Patel SJ and Sneige N: Her-2/neu gene amplification in breast imprint cytology analysed by FISH: Direct comparison with companion tissue sections. Diagn Cytopathol 23(5): 299-302, 2000.
33. Stark A, Hulka BS, Joens S, Novotny D, Thor AD, Wold LE, Schell MJ, Melton III JL, Liu TE and Conway K: HER-2/neu amplification in benign breast disease and the risk of subsequent breast cancer. J Clin Oncol 18(2): 267-274, 2000.
34. Rao TY, Apple SK, Jin Y, Lin S, Nieberg RK and Hirtschowitz SL: Comparative polymerase chain reaction analysis of c-myc amplification on archival breast fine-needle aspiration materials. Cancer Epidemiol Biomarkers Prev 9(2): 175-179, 2000.
35. Lizard-Nacol S, Lidereau R, Collin F, Arnal M, Hahnel L, Roignot P, Cuisenier J and Guerrin J: Benign breast disease: absence of genetic alterations at several loci implicated in breast cancer malignancy. Cancer Res 55: 4416-4419, 1995.
36. Amari M, Suzuki A, Moriya T, Yoshinga K, Amano G, Sasano H, Ohuchi N, Satomi S and Horii A: LOH analyses of premalignant and malignant lesions of human breast: frequent LOH in 8p, 16q, 17q in atypical ductal hyperplasia. Oncol Rep 66(6): 1277-1284, 1999.
37. Fiche M, Avet-Loiseau H, Maugard CM, Sagan C: Heymann M-F, Leblanc M, Classe J-M, Fumoleau P, Dravet F, Mahe M and Dutrillaux B: Genes amplification detected by fluorescence in-situ hybridization in pure intraductal breast carcinomas: relation to morphology, cell proliferation and expression of breast cancer-related genes. Int J Cancer (Pred Oncol) 89: 403-410, 2000.
38. Johansson B, Mertens F and Mitelman F: Primary vs. secondary neoplasia associated chromosomal abnormalities - balanced rearrangements vs. genomic imbalances? Genes Chromosomes Cancer 16: 155-163, 1996.
39. Mitelman F, Johansson B and Mertens F: Fusion genes and rearranged genes as a linear function of chromosome aberrations in cancer. Nat Genet 36(4): 331-334, 2004.
40. Teixeira MR, Pandis N, Bardi G, Andersen JA, Mandahl N, Mitelman F and Heim S: Cytogenetic analysis of multifocal breast carcinomas: detection of unrelated clones as well as clonal similarities between tumour foci. Br J Cancer 70: 922-927, 1994.
41. Tsarouha H, Pandis N, Bardi G, Teixeira MR, Andersen JA and Heim S: Karyotypic evolution in breast carcinomas with i(1)(q10) and der(1 ;16)(q10;p10) as the primary chromosome abnormality. Cancer Genet Cytogenet 113: 156-161, 1999.